Journals / Erciyes Tıp Dergisi / 2011 / Cilt: 33 - Sayı: 2

Topikal mupirosine bağlı yenidoğan ürtikeri

Neonatal urticaria due to topical mupirocin

Pages
149–152
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We herein report a newborn who developed urticaria due to mupirocin ointment, which has not been reported previously, and aimed to discuss the treatment of this rare condition in newborns.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Urticaria is one of the most common childhood dermatoses, but is uncommon under the age of 6 months.
📊
Key Findings & Data:As urticaria is uncommon under the age of 6 months and very few medications have been tested for safety or efficacy in this age group, there is little information in the literature regarding its therapy.
💡
Conclusion & Impact:We herein report a newborn who developed urticaria due to mupirocin ointment, which has not been reported previously, and aimed to discuss the treatment of this rare condition in newborns.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Urticaria is one of the most common childhood dermatoses, but is uncommon under the age of 6 months. There are only few studies defining the characteristics, etiology and therapy of urticaria in this age group. As urticaria is uncommon under the age of 6 months and very few medications have been tested for safety or efficacy in this age group, there is little information in the literature regarding its therapy. We herein report a newborn who developed urticaria due to mupirocin ointment, which has not been reported previously, and aimed to discuss the treatment of this rare condition in newborns.

Özet

Ürtiker çocukluk çağında sık görülen deri hastalıklarından biridir, ancak 6 aydan küçük yaşta nadirdir. Bu yaş grubuna özgü ürtikerin özelliklerini, etyolojisini ve tedavisini tanımlayan sadece birkaç çalışma vardır. Ürtiker 6 aydan küçüklerde nadir olduğundan ve bu yaş grubunda sadece bir kaç tedavinin etkinliği ve güvenilirliği denenmiş olduğundan, literatürde tedavisi ile ilgili çok az bilgi mevcuttur. Bu yazıda, daha önce bildirilmemiş olan mupirosine bağlı yenidoğan ürtiker olgusu sunularak yenidoğanlardaki bu nadir durumu tartışmayı amaçladık.

🔖

Cite This Article

SARICI, S. Ü., ERDEVE, Ş. S., ERDEVE, Ö. (2022). Topikal mupirosine bağlı yenidoğan ürtikeri. Erciyes Tıp Dergisi, Cilt: 33 - Sayı: 2, 149–152. https://ajindex.com/articles/502508

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Legrain V, Taieb A, Sage T, Maleville J. Urticaria in infants: a study of forty patients. Pediatric Dermatol 1990; 7:101-107
  2. Mortureux P, Léauté-Labrèze C, Legrain-Lifermann V, Lamireau T, Sarlangue J, Taïeb A. Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol 1998;134:319-23
  3. Carder KR. Hypersensitivity reactions in neonates and infants. Dermatol Ther 2005; 18:160-175
  4. Twarog FJ. Urticaria in childhood: pathogenesis and management. Pediatr Clin North Am 1983; 30:887-898
  5. Plumb J, Norlin C, Young PC, Utah Pediatric Practice Based Research Network. Exposures and outcomes of children with urticaria seen in pediatric practice-based research network: a case-control study. Arch Pediatr Adolesc Med 2001; 155:1017-1021
  6. American Society of Health Systems Pharmacists. Mupirocin. In: Gerald K. McEvoy;ed. AHFS Drug Information 2001. Bethesda: Maryland; 2001. p:3319- 3322
  7. Praz SM, de Torrenté A, Zender H, Schmied E, Schleppy CA, Genné D. Toxic epidermal necrolysis after topical intranasal application of mupirocin. Infect Control Hosp Epidemiol 2003; 24:459-60
  8. Simons FE, Silas P, Portnoy JM, Catuogno J, Chapman D, Olufade AO. Safety of cetirizine in infants 6 to 11 months of age: a randomized, double-blind, placebo- controlled study. J Allergy Clin Immunol 2003; 111: 1244-1248
  9. Ekins-Daukes S, Helms PJ, Taylor MW, McLay JS. Off- label prescribing to children: attitudes and experience of general practitioners. Br J Clin Pharmacol 2005; 60: 145-149.